Immune Checkpoint Inhibitors in Malignant Melanoma: Anti-PD-1, Anti-CTLA-4 and Anti-LAG-3 Therapies. - Allen-Tejerina AM; Giannakis P; Ho Lai Yau T; Hillyar CRT; Rallis KS (Current oncology reports, 2026)